Phase II trial shows combined avelumab and chemotherapy aims to improve outcomes in gastric cancer, indicating the role of biomarkers in treatment response.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Alsina et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: